Publicaciones en colaboración con investigadores/as de University of California, San Francisco (4)

2015

  1. The position of strontium ranelate in today’s management of osteoporosis

    Osteoporosis International, Vol. 26, Núm. 6, pp. 1667-1671

2014

  1. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment

    The Lancet Diabetes and Endocrinology, Vol. 2, Núm. 8, pp. 634-647

2004

  1. Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

    Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761

  2. The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

    New England Journal of Medicine, Vol. 350, Núm. 5, pp. 459-468